As of January 23, 2025, Omega Therapeutics (OMGA) has a market cap of $26.299 million USD. According to our data, Omega Therapeutics is ranked No.8489 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $26.30 M |
-36.33%
|
Dec 31, 2024 | $41.30 M |
-75.22%
|
Dec 29, 2023 | $0.17 B |
-47.29%
|
Dec 30, 2022 | $0.32 B |
-49.60%
|
Dec 31, 2021 | $0.63 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Beam Therapeutics
BEAM
|
$2.19 B |
0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
Fate Therapeutics
FATE
|
$0.15 B |
0.000 M
|
USA
|
Allogene Therapeutics
ALLO
|
$0.40 B |
0.000 M
|
USA
|
Precision BioSciences
DTIL
|
$38.13 M |
0.000 M
|
USA
|
Cellectis
CLLS
|
$0.16 B |
4.659 M
|
France
|
Poseida Therapeutics
PSTX
|
$0.93 B |
0.000 M
|
USA
|
Verve Therapeutics
VERV
|
$0.66 B |
0.000 M
|
USA
|
Market Cap | = | OMGA Stock Price | * | OMGA Shares Outstanding |
= | $0.47 | * | 55.37 M | |
= | $26.30 M |